Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Radziszewski

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
European Urology|November 26, 2018
Re: Are We Improving Erectile Function Recovery After Radical Prostatectomy? Analysis of Patients Treated over the Last DecadePiotr Radziszewski, Piotr Zapała
European Urology|November 13, 2018
Re: A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain SyndromePiotr Radziszewski, Łukasz Zapała
Central European Journal of Urology|March 1, 2014
Editorial commentSławomir Poletajew, Piotr Radziszewski
Central European Journal of Urology|July 2, 2014
Letter to the editorSławomir Poletajew, Piotr Radziszewski
European Urology|February 5, 2019
Re: Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled TrialPiotr Radziszewski, Sławomir Poletajew
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|April 29, 2003
[Therapeutic effects of intrarectal administration of oxybutynin]Piotr Radziszewski, Andrzej Borkowski
Central European Journal of Urology|May 4, 2017
Endoscopic appearance of a tumor can predict the stage of bladder cancerSławomir Poletajew, Piotr Radziszewski
European Urology|May 22, 2022
Re: Bladder Cancer in Patients Younger than 40 Years: Outcomes from the National Cancer Database de la Calle CM, Washington SL 3rd, Lonergan PE, et al World J Urol 2021;39:1911-6Piotr Radziszewski, Waldemar Szabłoński
European Urology|March 29, 2022
Re: Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk GroupsPiotr Radziszewski, Aleksander Ślusarczyk
European Urology|September 24, 2013
Incontinence: do we speak the same language?Piotr Radziszewski, Bartosz Dybowski
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
European Urology|November 26, 2018
Re: Are We Improving Erectile Function Recovery After Radical Prostatectomy? Analysis of Patients Treated over the Last DecadePiotr Radziszewski, Piotr Zapała
European Urology|November 13, 2018
Re: A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain SyndromePiotr Radziszewski, Łukasz Zapała
Central European Journal of Urology|March 1, 2014
Editorial commentSławomir Poletajew, Piotr Radziszewski
Central European Journal of Urology|July 2, 2014
Letter to the editorSławomir Poletajew, Piotr Radziszewski
European Urology|February 5, 2019
Re: Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled TrialPiotr Radziszewski, Sławomir Poletajew
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|April 29, 2003
[Therapeutic effects of intrarectal administration of oxybutynin]Piotr Radziszewski, Andrzej Borkowski
Central European Journal of Urology|May 4, 2017
Endoscopic appearance of a tumor can predict the stage of bladder cancerSławomir Poletajew, Piotr Radziszewski
European Urology|May 22, 2022
Re: Bladder Cancer in Patients Younger than 40 Years: Outcomes from the National Cancer Database de la Calle CM, Washington SL 3rd, Lonergan PE, et al World J Urol 2021;39:1911-6Piotr Radziszewski, Waldemar Szabłoński
European Urology|March 29, 2022
Re: Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk GroupsPiotr Radziszewski, Aleksander Ślusarczyk
European Urology|September 24, 2013
Incontinence: do we speak the same language?Piotr Radziszewski, Bartosz Dybowski
Pageof 17